» Articles » PMID: 38509360

A Host-microbiota Interactome Reveals Extensive Transkingdom Connectivity

Abstract

The myriad microorganisms that live in close association with humans have diverse effects on physiology, yet the molecular bases for these impacts remain mostly unknown. Classical pathogens often invade host tissues and modulate immune responses through interactions with human extracellular and secreted proteins (the 'exoproteome'). Commensal microorganisms may also facilitate niche colonization and shape host biology by engaging host exoproteins; however, direct exoproteome-microbiota interactions remain largely unexplored. Here we developed and validated a novel technology, BASEHIT, that enables proteome-scale assessment of human exoproteome-microbiome interactions. Using BASEHIT, we interrogated more than 1.7 million potential interactions between 519 human-associated bacterial strains from diverse phylogenies and tissues of origin and 3,324 human exoproteins. The resulting interactome revealed an extensive network of transkingdom connectivity consisting of thousands of previously undescribed host-microorganism interactions involving 383 strains and 651 host proteins. Specific binding patterns within this network implied underlying biological logic; for example, conspecific strains exhibited shared exoprotein-binding patterns, and individual tissue isolates uniquely bound tissue-specific exoproteins. Furthermore, we observed dozens of unique and often strain-specific interactions with potential roles in niche colonization, tissue remodelling and immunomodulation, and found that strains with differing host interaction profiles had divergent interactions with host cells in vitro and effects on the host immune system in vivo. Overall, these studies expose a previously unexplored landscape of molecular-level host-microbiota interactions that may underlie causal effects of indigenous microorganisms on human health and disease.

Citing Articles

Integrating multi-omics data to reveal the host-microbiota interactome in inflammatory bowel disease.

Su F, Su M, Wei W, Wu J, Chen L, Sun X Gut Microbes. 2025; 17(1):2476570.

PMID: 40063366 PMC: 11901428. DOI: 10.1080/19490976.2025.2476570.


Minocycline Ameliorates -Induced Neuroinflammation and Anxiety-like Behaviors by Regulating the TLR2 and STAT3 Pathways in Microglia.

Zou J, Gao J, Shang W, Fan X Brain Sci. 2025; 15(2).

PMID: 40002461 PMC: 11853265. DOI: 10.3390/brainsci15020128.


CD47 prevents Rac-mediated phagocytosis through Vav1 dephosphorylation.

Miller W, Mishra A, Sheedy C, Bond A, Gardner B, Montell D bioRxiv. 2025; .

PMID: 39990418 PMC: 11844498. DOI: 10.1101/2025.02.11.637707.


IgG-seq identifies immune-reactive enteric bacteria in Crohn's disease with spondyloarthritis.

Maldarelli G, Metz M, Oguntunmibi S, Tran N, Xiang G, Lukin D Gut Microbes. 2025; 17(1):2464221.

PMID: 39949039 PMC: 11834481. DOI: 10.1080/19490976.2025.2464221.


Skin microbiome and dermatologic disorders.

Scharschmidt T, Segre J J Clin Invest. 2025; 135(3).

PMID: 39895627 PMC: 11785926. DOI: 10.1172/JCI184315.


References
1.
Ruff W, Greiling T, Kriegel M . Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol. 2020; 18(9):521-538. DOI: 10.1038/s41579-020-0367-2. View

2.
Fan Y, Pedersen O . Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2020; 19(1):55-71. DOI: 10.1038/s41579-020-0433-9. View

3.
Fischbach M . Microbiome: Focus on Causation and Mechanism. Cell. 2018; 174(4):785-790. PMC: 6094951. DOI: 10.1016/j.cell.2018.07.038. View

4.
Niemann H, Schubert W, Heinz D . Adhesins and invasins of pathogenic bacteria: a structural view. Microbes Infect. 2004; 6(1):101-12. DOI: 10.1016/j.micinf.2003.11.001. View

5.
Poole J, Day C, von Itzstein M, Paton J, Jennings M . Glycointeractions in bacterial pathogenesis. Nat Rev Microbiol. 2018; 16(7):440-452. DOI: 10.1038/s41579-018-0007-2. View